Flow and Pressure during Liver Preservation under ex situ and in situ Perfusion with University of Wisconsin Solution and Histidine-Tryptophan-Ketoglutarate Solution

Effective preservation of liver grafts is the first essential step for successful liver transplantation. Insufficient perfusion leads to ischemic-type biliary lesions after transplantation. Perfusion of the graft can be performed either in situ or ex situ, with gravity flow or pressure-controlled. Mainly University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solutions are used widespread in clinical liver transplantation. Due to a persistent lack of data, we performed this systematic investigation of in situ and ex situ perfusion of liver grafts with HTK (low-viscous) and UW (high-viscous) solutions at different pressure steps on the perfusion solution (gravity flow, 50, 100, 150, and 200 mm Hg). End points were perfusion flow and pressure in the hepatic artery. A pig model was used with n = 8 pigs randomized to each (HTK and UW) group. In situ perfusion was ineffective for both solutions at any pressure on the perfusate bag. Ex situ perfusion showed significantly improved flow and pressure in the hepatic artery and, therefore, was highly effective. No major differences between HTK and UW solutions could be detected. Therefore, an additional ex situ perfusion of the hepatic artery should be mandatory in every liver procurement.

[1]  G. Otto,et al.  Ischemic Type Biliary Lesions in Histidine-Tryptophan-Ketoglutarate (HTK) Preserved Liver Grafts , 2006, The International journal of artificial organs.

[2]  P. Olinga,et al.  Initial Blood Washout During Organ Procurement Determines Liver Injury and Function After Preservation and Reperfusion , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  M. Malago',et al.  Histidine‐tryptophan‐ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: Results of a prospective study , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  B. Ringe,et al.  Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. , 2003, International surgery.

[5]  G. Otto,et al.  Prevention of ischemic‐type biliary lesions by arterial back‐table pressure perfusion , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  P. Friend,et al.  Liver and kidney preservation by perfusion , 2002, The Lancet.

[7]  D. Kranz,et al.  Organ preservation with EC, HTK, and UW, solution in orthotopic rat liver transplantation. Part II. Morphological study. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[8]  C. Bodian,et al.  Retransplantation for late liver graft failure: Predictors of mortality , 1998, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  H. Bismuth,et al.  Beneficial effects of Eurocollins as aortic flush for the procurement of human livers. , 1996, Transplantation.

[10]  Reinhold Scherer,et al.  Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  C. Herfarth,et al.  Biliary complications after prolonged University of Wisconsin preservation of liver allografts. , 1993, Transplantation proceedings.

[12]  E. M. Ward,et al.  Ischemic‐type biliary complications after orthotopic liver transplantation , 1992, Hepatology.

[13]  K. Olthoff,et al.  Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. , 1990, Transplantation.

[14]  T. Starzl,et al.  Extended preservation of human liver grafts with UW solution. , 1989, JAMA.

[15]  B. Griffith,et al.  A flexible procedure for multiple cadaveric organ procurement. , 1984, Surgery, gynecology & obstetrics.

[16]  T. Vogl,et al.  [Etiologic factors and incidence of ischemic type biliary lesions (ITBL) after liver transplantation]. , 1998, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress.